MRP1与ToPo-Ⅱ在非小细胞肺癌的表达及其临床意义 |
| |
引用本文: | 顾岩,;李国华,;高俊珍,;郭丽萍,;乔晓娟,;贺岚,;王关玲,;闫丽,;付秀华.MRP1与ToPo-Ⅱ在非小细胞肺癌的表达及其临床意义[J].中华临床医师杂志(电子版),2014(18):31-35. |
| |
作者姓名: | 顾岩 ;李国华 ;高俊珍 ;郭丽萍 ;乔晓娟 ;贺岚 ;王关玲 ;闫丽 ;付秀华 |
| |
作者单位: | [1]内蒙古医科大学附属医院呼吸内科,呼和浩特010050; [2]内蒙古医科大学附属医院保健中心,呼和浩特010050 |
| |
摘 要: | 目的探讨MRP1、ToPo-Ⅱ在非小细胞肺癌(NSCLC)中的表达及其临床意义。方法采用免疫组织化学法检测117例NSCLC,26例对照组断端支气管黏膜中MRP1、ToPo-Ⅱ的表达水平。结果 (1)MRP1在NSCLC阳性表达高于对照组(P<0.05),与组织类型、分期、淋巴结转移有关(P<0.05);MRP1在鳞癌中的表达低于腺癌(P<0.05);随分期增高,淋巴结转移表达增强;MRP1表达与性别、年龄、分化无关(P>0.05)。(2)ToPo-Ⅱ表达在NSCLC组高于对照组(P<0.05);与组织类型、分化有关(P<0.05);鳞癌ToPo-Ⅱ表达高于腺癌;随分化程度降低表达增强(P<0.05);ToPo-Ⅱ与性别、年龄、分期、淋巴结转移无关(P>0.05)。(3)MRP1与ToPo-Ⅱ呈负相关(r=-0.269,P<0.05)。结论 NSCLC存在MRP1及ToPo-Ⅱ的高表达,两者可能参与肿瘤进展。
|
关 键 词: | 癌 非小细胞肺 多药耐药相关蛋白质类 DNA拓扑异构酶类 Ⅱ型 |
Expression and clinical significance of multidrug resistance associated protein-1 and DNA topoisomerase-Ⅱ |
| |
Institution: | Gu Yan, Li Guohua, Gao Junzhen, Guo Liping, Qiao Xiaojuan, He Lan, Wang Meiling, Yan Li, Fu Xiuhua.( Department of Respiratory Medicine, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, China) |
| |
Abstract: | Objective To investigate the expression and clinical significance of multidrug resistance associated protein-1 and DNA topoisomerase-Ⅱ. Methods MRP1 and ToPo-Ⅱ were measured in 117 samples of non-small cell lung cancer tissues by immunohistochemistry two-step method using monoclonal antibody to their protein. Results The positive expression of MRP1 was higher than that in sectional bronchial mucosa (P〈0.05);MRP1 expression in adenocarcinoma (Ad) was significantly higher than that in squamous carcinoma (P〈0.05); The positive expression of MRP1 in Ⅲ stage group was higher than that in I stage group (P〈0.05);MRP1 expression correlated significantly with lymph node metastasis; But the positive rate of the expression of MRP1 had no significantly different between the different degrees of cell differentiation (P〉0.05). The positive rate of ToPo-Ⅱ was significantly higher in the group of the squamous cell carcinomas than that in that of the adenocarcinoma (P〈0.05); ToP o-Ⅱexpression in the poorly differentiated group was higher than one in highly differentiated group; The positive rates of ToPo-Ⅱ was not correlated with TMN stage and lymph node metastasis. ToPo-Ⅱexpression correlated with MRP1(r=-0.269, P〈0.05). Conclusion The coexpression of MRP1 and ToPo-Ⅱ could be involved in the advanced NSCLC . |
| |
Keywords: | Carcinoma non-small-cell lung Multidrug resistance-associated proteins DNATopoisomerases type Ⅱ |
本文献已被 维普 等数据库收录! |
|